twitternames_tweets
@dfpwriter @DrAdrianHeald @nurse_marcus eg https://t.co/7OrzhTdtBz
RT @goyoiraola: Nuevo estudio sugiere que la mutaci√≥n D614G conferir√≠a una mayor capacidad de transmisi√≥n al #SARSCoV2 Los genomas que hem‚Ä¶
"@PoliticJeremiah @applefodder @zeezaluh @TheRightMelissa @realDonaldTrump Wait, what are you even SAYING here? The literal NAME of covid is SARS-CoV-2. And here https://t.co/0boNct7svH the study the article links to. A mutation that occured in Europe S"
@salocinuy https://t.co/J8SxbbKoyi
"RT @daniel_bilar: #LANL Spike mutation D614G #ncov2019 strain [ACE2, delC allele easier entry (E Asian--- but Euros++ & NorAms+); likely R+‚Ä¶"
@Alexis_Cossette Une √©tude non-revis√©e par les paires mais unavant go√ªt...https://t.co/MPKt9BkRZj
RT @dr_gsharma: 8 Further Update G614 Mutation has caught interest of scientists globally. This clade is way more transmissible & many fata‚Ä¶
#LANL D614G isolate / strain #ncov2019 https://t.co/4JcQggda0f > world-wide data story well told SME @39Magilla https://t.co/pdfsnuz4W5 > Pro: R++ plausible SME @trvrb https://t.co/sCRj7F44sP > Contra: founder effect [noise error-prone RNA syn
8 Further Update G614 Mutation has caught interest of scientists globally. This clade is way more transmissible & many fatalities are from this mutation type only. Once it appeared in a region then it soon became dominant type. Excellent thread on this
"Researchers from @LosAlamosNatLab, @SheffieldHosp and @TheDHVI have found 14 mutations to the SARS-CoV-2 virus. Read more here: https://t.co/46OvKxFvLo. @bettekorber1 https://t.co/wETyEXnmIb"
My initial assessment of https://t.co/wLITRh3CjP - this is 'Promising' research. Read the review in full at https://t.co/kgQnd0iIY6 #covid19 #everyreviewcounts
"#LANL Spike mutation D614G #ncov2019 strain [ACE2, delC allele easier entry (E Asian--- but Euros++ & NorAms+); likely R++, CFR+; can explain worldwide variations eg NYC 1/500 vs 1/4000; viral & clinical https://t.co/Oj3EnsjN7m ; IMHO bad news for"
Ê¨ßÂ∑ûÊ†™„ÅÆÊÑüÊüìÊÄß„ÄÇ / https://t.co/xG03lnsRV8
RT @2u3v4w: @hidekih @ABOFAN @rhwtsh @dorakuns @Isseki3 Ê¨ßÂ∑ûÊ†™„ÅØ„Ç¶„Ç§„É´„Çπ„ÅÆÊßãÈÄ†„Åã„ÇâÊÑüÊüìÊÄß„ÅåÈ´ò„ÅÑ„Å®Êé®ÂÆö„Åï„Çå„Å¶„ÅÑ„Åæ„Åô„Å≠„ÄÇÊØíÊÄß„ÅØ‰∏çÊòé„ÄÇ „Åù„ÅÆÊôÇÊúü„ÅÆÊÑüÊüìËÄÖÊï∞„ÅØimported„Å®„Åó„Å¶Âèñ„ÇäËæº„Åæ„Çå„Å¶„ÅÑ„Åæ„Åô„Åå„ÄÅ„Åª„ÅºÊ¨ßÂ∑ûÊ†™„Åß„ÅÇ„Çã„Åì„Å®„ÅåÂàÜ„Åã‚Ä¶
@hidekih @ABOFAN @rhwtsh @dorakuns @Isseki3 Ê¨ßÂ∑ûÊ†™„ÅØ„Ç¶„Ç§„É´„Çπ„ÅÆÊßãÈÄ†„Åã„ÇâÊÑüÊüìÊÄß„ÅåÈ´ò„ÅÑ„Å®Êé®ÂÆö„Åï„Çå„Å¶„ÅÑ„Åæ„Åô„Å≠„ÄÇÊØíÊÄß„ÅØ‰∏çÊòé„ÄÇ „Åù„ÅÆÊôÇÊúü„ÅÆÊÑüÊüìËÄÖÊï∞„ÅØimported„Å®„Åó„Å¶Âèñ„ÇäËæº„Åæ„Çå„Å¶„ÅÑ„Åæ„Åô„Åå„ÄÅ„Åª„ÅºÊ¨ßÂ∑ûÊ†™„Åß„ÅÇ„Çã„Åì„Å®„ÅåÂàÜ„Åã„Å£„Å¶„ÅÑ„Çã„ÅÆ„Åß„ÄÅËÄÉÊÖÆÊ∏à„Åø„Å†„Å®ÊÄù„ÅÑ„Åæ„Åô„ÄÇ Êó•Êú¨„Åß„ÅØÊ≠¶Êº¢Ê†™„ÅÆÊÑüÊüì„ÅØ2ÊúàÊú´„ÅßÁµÇ„Çè„Å£„Å¶„ÅÑ„Åæ„Åô„ÄÇ https://t.co/e0fVXFkvLD
"Here's a link to the paper that's causing waves, asserting that the D614G mutation in SARS-CoV-2 is gaining dominance. The text has an error in the highlighted part of this screenshot. It's not germane to the discussion, but it's unsettling. It's A-to-G."
RT @chrislhayes: This paper makes the case that the version of Corona virus mutation that spread through Europe and then came to NY is cons‚Ä¶
RT @39Magilla: #Fauci #DrFauci #FauciTestimony @FauciFans #MedTwitter #COVIDfoam #D614G @LosAlamosNatLab https://t.co/KSvrKV2LoK
RT @39Magilla: @RaviBatra Here is the research report link and a link to my thread on the subject: https://t.co/OHd7aB3W9u https://t.co/KS‚Ä¶
On the virus mutating and becoming more contagious: - he talks about this publication: https://t.co/hMP4gHX1av - explains that the mutation mentioned in the publication might be the cause for the virus to be more #contagious. However it also could be the
RT @39Magilla: (1) Could #COVID19 mutant #D614G the variation seen in Transmission Rates (Rt's) and Case Fatality Rates (CFR's) between loc‚Ä¶
@Scottgunz @FukerGnarlson69 @mattyda_12 @David_Leavitt It was linked quite prominently in the article: https://t.co/IbotBug962
RT @39Magilla: #Fauci #DrFauci #FauciTestimony @FauciFan @lbfeldman @LVBurke @jayoung1892 @gracibeaucoup
RT @LaurelCoons: Is D614G Mutation A New Strain? üß¨More #evidence is needed to make determination üß¨We know mutation shows no measurable ef‚Ä¶
Still waiting on the peer review of this one! https://t.co/ILVn14oi9I
Great discussion of why the D614G mutation's predominance may tie back in to a founder effect. #SARSCoV2
"Yup, but our Russian leader, trump, under direct orders from his boss, Putin, is forcing governors whom are trying to keep their people safe, to open. Trump thinks this will help him get re-elected. Fat chance freakshow"
RT @trvrb: @chrislhayes Here was my take on this: https://t.co/Le2g1eDtRr
RT @trvrb: I wanted to address the hypothesis put forward in Korber et al (https://t.co/ouM4IUyNrd) that the mutation in spike protein D614‚Ä¶
interesting thread about #SARSCoV2 mutants
@genomepandit Here is the research report link and a link to my thread on the subject: https://t.co/OHd7aB3W9u https://t.co/KSvrKV2LoK
Here is the research report link and a link to my thread on the subject: https://t.co/OHd7aB3W9u https://t.co/KSvrKV2LoK
@KlausRiede @BNF75 Here is the research report link and a link to my thread on the subject: https://t.co/OHd7aB3W9u https://t.co/KSvrKV2LoK
@RaviBatra Here is the research report link and a link to my thread on the subject: https://t.co/OHd7aB3W9u https://t.co/KSvrKV2LoK
@BrianOSheaSPI Here is the research report link and a link to my thread on the subject: https://t.co/OHd7aB3W9u https://t.co/KSvrKV2LoK
"Here's the paper for you guys that I think is most useful and relevant. Wuhan faced an ancestral clade outside of A2 and, crucially, D614G. We can be pretty sure that D614G confers a gain of function as it is conserved and has evolved multiple times. ht"
@iampawannathani Here is the research report link and a link to my thread on the subject: https://t.co/4mgDwU8W6q https://t.co/KSvrKV2LoK
Interesting article
#=@JoeNBC @morningmika @WillieGeist @AliVelshi @SRuhle @mitchellreports @DeadlineWH @MeetThePress @AriMelber @chrislhayes @maddow
#Fauci #DrFauci #FauciTestimony @FauciFans #MedTwitter #COVIDfoam #D614G @LosAlamosNatLab
#Fauci #DrFauci #FauciTestimony @FauciFan @lbfeldman @LVBurke @jayoung1892 @gracibeaucoup
Áâπ„Å´ÂçÅÂàÜ„Å´Ê≥®ÊÑè„Åô„Çã‰∫ã„ÅØ‰∫åÁ®ÆÈ°û„ÅÆ„Ç¶„Ç§„É´„Çπ„ÅåÊÑüÊüì„Åó„ÅüÊôÇ„ÅÆ‰∫ã„Å†„Å®„ÄÇ‰∏°„Ç¶„Ç§„É´„ÇπÈñì„ÅßÈÅ∫‰ºùÂ≠êÁµÑ„ÅøÊèõ„Åà„ÅåË°å„Çè„Çå„ÅüÊôÇ„Å´„ÄÅ„Å©„ÅÜÊåôÂãï„ÅåÂ§âÂåñ„Åô„Çã„ÅãÔºü„ÅÑ„ÅæÂøÖË¶Å„Å™„ÅÆ„ÅØÂõΩÂÜÖ„ÅßÂ∫É„Åå„Çã„Ç¶„Ç§„É´„Çπ„ÅÆRNAÂûã„Åå„Å©„ÅÆ„Çà„ÅÜ„Å´Êã°Êï£„Åó„Å¶„Çã„ÅãÔºüËøΩË∑°„ÅåÈáçË¶Å„Å†„Å©„Åï„ÄÇü§™üí¢üëÖÂÖ®„Ç≤„Éé„É†Ëß£Êûê„Å´Èä≠„Å™„Å©„Åë„Å°„Çã„Å™ÂÆâÂÄç„ÇàÔºÅüí¢ https://t.co/xfU7lNOFtx https://t.co/Dj3azLPHoO
"@aberron @CMatallanas15 Y podr√≠a ser porque haya una mutaci√≥n del virus que los tests de anticuerpos no detectan, tal y como sugiere este art√≠culo: https://t.co/D1j9coVU4c"
üò≥
"RT @Rschooley: So definitely easing up so that strain spreads over the country is the move, right?"
Mutation. It‚Äôs inevitable.
@SSG_PAIN @martingeddes https://t.co/f0GYpVqdeF
RT @marissa_rae: This has been been my working primary hypothesis since the different continental vector data was published ~a month ago. G‚Ä¶
May explain some things
Why are msnbc hosts reading bioarxiv when I haven‚Äôt even been reading bioarxiv
Here we go...I know this paper is not peer reviewed but preliminaries are frequently flags for what is to come...2nd Pandemic comes to mind.
RT @ARanganathan72: Excellent (non-peer-reviewed) study published today by Indian scientists reveals a unique mutation in the Indian SARS-C‚Ä¶
@CNBCi https://t.co/7MRcwY5kz3
https://t.co/PZSEbTENS8
RT @Mareq16: CoVID 19: Variants of Covid by area: https://t.co/SX5z3lgqYM
CoVID 19: Variants of Covid by area: https://t.co/SX5z3lgqYM
@ARanganathan72 Not sure whether our scientists have gotten enough support after their discovery of the role of miR-27b in SARS-CoV2 infection https://t.co/KfXpYU0TpB
https://t.co/mENXBd2lOM India specific mutation may make the virus more susceptible to anti hivprotease inhibitors
RT @Cholesterolfun1: https://t.co/3dl8TDEpf2
https://t.co/3dl8TDEpf2
@nishchayapallav Sorry I haven't bookmarked it but have pdf https://t.co/XHdOPi9GqL
Comparative analyses of SAR-CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host-virus interaction and pathogenesis https://t.co/DlmOgahDV9
@AntonWeye @skeptic247 Different strain of virus üëá https://t.co/yWThj5s3aG
@DemocratYellow Here's another paper (not peer reviewed) that seems to talk about SARS-CoV-2 strain in India being different: https://t.co/iBrfRVVOFi
https://t.co/cdmiDVnMkz
Comparative analyses of SAR-CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host-virus interaction and pathogenesis https://t.co/Xq1h9NkQ25
@LeftRants Check this read what's the difference between Chinese and Indian strain. Also the genome is deciding factor if a person shows up the symptoms early or asymptotic. https://t.co/XHdOPirhPl
@doplaza @medel2020 https://t.co/lHtrn3cT2z
"RT @Kannan9900: .@_atanas_ MicroRNA, the miracle drug against Covid-19? A milestone in Covid19-research. Role for: >> anti-viral human mi‚Ä¶"
"@paimadhu This study is being circulated back home in India. Not even peer reviewed, but people are buying it. https://t.co/yOoDqLNM4p Many news/YouTube channels have filmed dramatic pieces about this paper saying that the Indian genome is different. I don"
https://t.co/4hsGnaThgW
@JohnsHopkins ‡§ï‡•á ‡§™‡•Ä‡§ü‡§∞ ‡§•‡•Ä‡§≤‡•á‡§® ‡§ï‡•ã‡§∞‡•ã‡§®‡§æ ‡§µ‡§ø‡§∑‡§æ‡§£‡•Å ‡§ï‡•á 1000 ‡§∏‡•á ‡§ú‡•ç‡§Ø‡§æ‡§¶‡§æ ‡§Ö‡§≤‡§ó-2 ‡§®‡§Æ‡•Ç‡§®‡•ã‡§Ç ‡§ï‡§æ ‡§Ö‡§ß‡•ç‡§Ø‡§Ø‡§® ‡§ï‡§∞ ‡§∞‡§π‡•á ‡§π‡•à‡§Ç‡•§ ‡§â‡§®‡§ï‡•á ‡§Ö‡§®‡•Å‡§∏‡§æ‡§∞ ‡§ï‡•ã‡§∞‡•ã‡§®‡§æ ‡§µ‡§ø‡§∑‡§æ‡§£‡•Å ‡§∏‡§Ç‡§∞‡§ö‡§®‡§æ ‡§Æ‡•á‡§Ç ‡§§‡•á‡§ú ‡§ó‡§§‡§ø ‡§∏‡•á ‡§™‡§∞‡§ø‡§µ‡§∞‡•ç‡§§‡§® ‡§®‡§π‡•Ä ‡§ï‡§∞ ‡§∞‡§π‡§æ ‡§π‡•à‡•§ ‡§µ‡•Å‡§π‡§æ‡§® ‡§î‡§∞ ‡§Ö‡§Æ‡•á‡§∞‡§ø‡§ï‡§æ ‡§ï‡•á ‡§®‡§Æ‡•Ç‡§®‡•ã‡§Ç ‡§Æ‡•á‡§Ç ‡§ï‡•á‡§µ‡§≤ 4 ‡§∏‡•á 10 ‡§™‡§∞‡§ø‡§µ‡§∞‡•ç‡§§‡§® ‡§Æ‡§ø‡§≤‡•á ‡§π‡•à‡§Ç‡•§ #COVID #COVID19Pandemic h
@colourmeamused_ https://t.co/fcL3KIMWdw Not peer reviewed.
"@ElonBachman This study published by Indian scientists reveals a unique mutation in the Indian SARS-CoVID-2 strain, and also that the potently anti-viral human microRNA (miRNA) hsa-miR-27b has a target in the Indian strain https://t.co/T7uNHmoemm Also on"
"@julloa_juan @medel2020 @Gabymartinezb Obviamente no deja de ser ü§î que un grupo de India reporte un miRNA en poblaciones Indias que le pega a la variante India del SARS-CoV-2, pero bueno. Ah√≠ est√° el pre-print para que se lo fileteen a piacere: https://t.c"
https://t.co/jMdUTwiF38
RT @drp_parikshya: Seems different strains of Corona virus affecting different parts of d globe. Interesting...huh!! Is it a selective con‚Ä¶
@AayeinKonchi @GiacintoFolino @KyaUkhaadLega A little mutation even in single Base pair can change the strain. Here is link for detailed study download the pdf https://t.co/XHdOPirhPl.
RT @purviparwani: This Preprint on #COVID19 https://t.co/BRyRMjfa73 üó£Ô∏èUnique mutation in the spike surface glycoprotein in the Indian #SAR‚Ä¶
RT @Iyervval: Translation into ENGLISH: the #COVID19 strain in India is a less virulent mutation. Uniquely it is able to be targetted and d‚Ä¶
1) This idea gained traction after this paper https://t.co/fUoT7nmvhE was posted on biorxiv. Biorxiv is a preprint server where ANYONE can post scientific manuscripts.
".@_atanas_ MicroRNA, the miracle drug against Covid-19? A milestone in Covid19-research. Role for: >> anti-viral human microRNA (miRNA)- hsa-miR 27b<< can neutralize Covid-19 mediated pathology. So far this microRNA27b works only against the"
"There is study published by Indian scientists reveals a unique mutation in the Indian SARS-#CoVID-2 strain, and also that the potently anti-viral human microRNA (miRNA) hsa-miR-27b has a target in the #Indian strain.. #Coronaindia #Coronavirustruth https"
"This Preprint on #COVID19 https://t.co/BRyRMjfa73 üó£Ô∏èUnique mutation in the spike surface glycoprotein in the Indian #SARSCoV2 (-ve)in other strains üó£Ô∏èwhile,52 host miRNAs predicted to have the same targets in all #SARSCoV2 genomes, an extra miRNA uniquely"
@edwardcholmes @KindrachukJason Check this paper https://t.co/IGalvB0A6r
"@aknappjr There is study published by Indian scientists reveals a unique mutation in the Indian SARS-CoVID-2 strain, and also that the potently anti-viral human microRNA (miRNA) hsa-miR-27b has a target in the Indian strain. https://t.co/T7uNHmoemm"
"@italiadati https://t.co/ED5isYejiV Bisognerebbe integrare la mutazione del genoma. Da questo studio indiano viene individuata una mutazione unica, per l‚ÄôItalia. I principali risultati nelle foto. https://t.co/GXKO3qOUXw"
@RaneyGary Interesting. I suppose it could be possible. It would be nice to see more direct evidence in human cases. https://t.co/Oebjl4vF2R
"@__ice9 There is study published by Indian scientists reveals a unique mutation in the Indian SARS-CoVID-2 strain, and also that the potently anti-viral human microRNA (miRNA) hsa-miR-27b has a target in the Indian strain ......they say https://t.co/T7uNHm"
"@Shakra_Kulish Sir, is wearing N95 or normal mask helpful in this situation? I'm getting conflicting messages about this."
#=@pavitrarc.. for your perusal And comments please
RT @sue9a: Misleading claims are being made from unpublished material off preprint servers @biorxivpreprint. The article https://t.co/7qj5V‚Ä¶
#Rubbish #dangerous
"RT @projectbasu: @ARanganathan72 As a Bioinformatics scientist, I can say that this study is wrong on deriving conclusions from single samp‚Ä¶"
"https://t.co/bDYCM4zaWw ""Systematic gene level mutational analysis of the genomes identify several unique features of SARS-CoV2 genome, which includes a unique mutation in the spike surface glycoprotein (A930V (24351C>T)) in the Indian SARS-CoV2, absent"
"https://t.co/pIQOFnLDY3 I've elementary level knowledge only in microbiology / genetics being a clinician, not an expert. Hope this promising finding proves true about a micro RNA unique only to Indian patients of SARS CoV 2 effecting mutation in virus re"
Seems different strains of Corona virus affecting different parts of d globe. Interesting...huh!! Is it a selective conspiracy by d virus/ *****(u Kno wat I mean). Or india is paying d price for US proximity..?? @nmprusty @jpsambit https://t.co/lzEAnKkMQf
"#=@aryanyogtas @anupsoans what Dr. Reddy said is based on a recent publication by Dr. Rahila Sardar from Translational Bioinformatics Group, International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi. you can read The paper Here http"
"Misleading claims are being made from unpublished material off preprint servers @biorxivpreprint. The article https://t.co/7qj5VGhWQQ made its way to WhatsApp group chats, heralding the ""immunity"" of Indians. And now this news item! Irresponsible reporting"
@GKangInd @samar11 @PriyankaPulla @ShekharGupta Are these news items related to this report and can you pls share your interpretation of the research? https://t.co/wyVMyiJt37
"@pavitrarc Are the discussions related to this report? https://t.co/wyVMyiJt37 I'm not a medical researcher, so asking to make more sense of this."
The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15 https://t.co/vhZL2KwbEJ
RT @DNA_RNA_Uni: New RNA #corona #preprints üìñ https://t.co/PPITLxUAZ7 https://t.co/ulnaw4VMtS https://t.co/a90tHU1OQ9 https://t.co/sgjm1rI‚Ä¶
RT @InceptionCap: @OscarDev3 Ciclesonide (Alvesco) research reference links: #1: https://t.co/o3mxo0Q72s #2: https://t.co/h2kqG9YxZe #3: Th‚Ä¶
RT @InceptionCap: Inhaled asthma Ciclesonide (Alvesco) research reference links: #1: https://t.co/o3mxo0Q72s #2: https://t.co/h2kqG9YxZe #3‚Ä¶
New RNA #corona #preprints üìñ https://t.co/PPITLxUAZ7 https://t.co/ulnaw4VMtS https://t.co/a90tHU1OQ9 https://t.co/sgjm1rIKq4 https://t.co/U1RSi0223m https://t.co/qhdFRE4VwX graphics by Matthew Butler #library #coronavirus #read #research @rnomics @Novog
@onodekita @BB45_Colorado https://t.co/RTNBRy28nU ‰ª•Ââç„ÄÅÊ≤ªÈ®ì„ÇÇ„Å™„ÅÑ„É°„ÇøË≠∞Ë´ñ„Çí„Åô„Çã„Å™„Å®Âè±„Çâ„Çå„Åü„ÉÑ„Ç§„Éº„ÉàË≤º„Å£„Å®„Åè„ÄÇ https://t.co/rCLv2gvyVB „Ç∑„ÇØ„É¨„ÇΩ„Éã„Éâ„ÅØËÄêÊÄß„ÇíË™òÂ∞é„Åó„ÇÑ„Åô„ÅÑ„ÄÇ ËÄêÊÄß„Å´„Å™„Å£„Åü„Ç¶„Ç§„É´„Çπ„Å´„É¢„É°„Çø„Çæ„É≥„Çí‰ΩúÁî®„Åï„Åõ„Çã„Å®ÊäëÂà∂„ÄÇ ‰ΩúÁî®ÁÇπ„ÅåÈÅï„ÅÜ„ÄÇ „É¢„É°„Çø„Çæ„É≥„ÅØÔºà‰ªä„ÅÆ„Å®„Åì„ÇçÔºâËÄêÊÄß„ÇíË™òÂ∞é„Åó„Å™„ÅÑ„ÄÇ
@AyannaPressley @Vivimor https://t.co/FluMm9dnyV
@KizzyPhD Actually it's inhaled ciclesonide. I mistyped that. Link to original study on that blocking viral replication of COVID-19. https://t.co/LcQ8kWbZK1
Inhaled asthma Ciclesonide (Alvesco) research reference links: #1: https://t.co/o3mxo0Q72s #2: https://t.co/h2kqG9YxZe #3: Three Human Cases: https://t.co/GZ24A9M4dj #4: https://t.co/2i74vzDf3Z #5: https://t.co/SbfHqf0LwQ #6: https://t.co/f941fXjtv5 #7: ht
@OscarDev3 Ciclesonide (Alvesco) research reference links: #1: https://t.co/o3mxo0Q72s #2: https://t.co/h2kqG9YxZe #3: Three Human Cases: https://t.co/GZ24A9M4dj #4: https://t.co/2i74vzDf3Z #5: https://t.co/SbfHqf0LwQ #6: https://t.co/f941fXjtv5 #7: https:
RT @__ice9: @KO_Sulli @InceptionCap Ciclesonide is the only one so far known to have antiviral properties. It acts against viral protein N‚Ä¶
@KO_Sulli @InceptionCap Ciclesonide is the only one so far known to have antiviral properties. It acts against viral protein NSP15. https://t.co/qZecYebvg8
@OscarDev3 @__ice9 @DrSamGirgis @lewistlc #1: Clinical trial link: https://t.co/o3mxo0Q72s ;#2: https://t.co/DZoVgJ7xlR ;#3: 3 human cases: https://t.co/GZ24A9M4dj ;#4: https://t.co/2i74vzDf3Z ;#5: https://t.co/f941fXjtv5 ;#6: https://t.co/ZzUqf1Uovk
@coccinelo @RobertoBurioni Below are links for articles about ciclesonide (Alvesco). It's anti-viral specifically for corona viruses. https://t.co/FM1tgMKoXU https://t.co/QgtXLNTGAR https://t.co/8b0eP2VGdH https://t.co/ZwFJZeYHlO
"#@highjournals @bodhibrian @niro60487270 I talked about ciclesonide As It seems to be The least harmful medicine that can help with Corona. I have used a lot of inhaled steroids like ciclesonide, none had any serious side effects. I have not seen any studie"
@Thinkerks @GoodmanZJeremy Ciclesonide (Alvesco) is being tested in 2 trials - in Japan and Korea. Further details below: https://t.co/FM1tgMKoXU https://t.co/QgtXLNTGAR https://t.co/ZwFJZeYHlO https://t.co/8b0eP2VGdH
@minhealthnz https://t.co/JYnOjYx6Rm
RT @inokura: @BB45_Colorado @WorldSystem7 Ê≤ªÈ®ìÈÄ≤Ë°å‰∏≠„Å†„Åë„Å©„ÄÅÂàùÊúüÊ≤ªÁôÇ„ÅØ„Ç∑„ÇØ„É¨„ÇΩ„Éã„Éâ„ÅåËâØ„ÅÑÊÑü„Åò„ÄÇ „É¢„É°„Çø„Çæ„É≥„ÅÆÁÇπÈºª„Å®Âê∏ÂÖ•„ÇÇ„ÄÇ „Éä„Çæ„Éç„ÉÉ„ÇØ„ÇπÁÇπÈºªÊ∞ó‰ºë„ÇÅ„Å´„Å©„ÅäÔºü „Ç¢„É´„Ç≤„Çπ„Éà„É≥„ÄÅ„Éü„Éï„Çß„Éó„É™„Çπ„Éà„É≥„ÅØÁµåÂè£ÈÅøÂ¶äËñ¨ The inhaled cort‚Ä¶
RT @H_Inomata: @decki0924 „Åæ„Å£„Åü„Åè„Åù„ÅÆÈÄö„Çä„ÄÇ https://t.co/3kVUmc7KpG „Åß„ÄÅ‰∏ÄË¶ã„ÄÅÊäó„Ç¶„Ç§„É´„Çπ‰ΩúÁî®„Åå„ÅÇ„Çä„Åù„ÅÜ„Å´Ë¶ã„Åà„Çã„Çì„Åß„Åô„Åå„ÄÅÊÑüÊüìÁ¥∞ËÉû„ÇÇÊ≠ª„Çì„Åò„ÇÉ„Å£„Å¶„ÅÑ„Çã„Åø„Åü„ÅÑ„Åß„Åô„Åã„Çâ„Å≠„ÄÇ„Å™„Çì„ÅßÊäó„Ç¶„Ç§„É´„Çπ‰ΩúÁî®„Å†„Åë„Å´Êãò„Çã„ÅÆ„Åã„Å®„ÄÇ https://t.c‚Ä¶
@decki0924 „Åæ„Å£„Åü„Åè„Åù„ÅÆÈÄö„Çä„ÄÇ https://t.co/3kVUmc7KpG „Åß„ÄÅ‰∏ÄË¶ã„ÄÅÊäó„Ç¶„Ç§„É´„Çπ‰ΩúÁî®„Åå„ÅÇ„Çä„Åù„ÅÜ„Å´Ë¶ã„Åà„Çã„Çì„Åß„Åô„Åå„ÄÅÊÑüÊüìÁ¥∞ËÉû„ÇÇÊ≠ª„Çì„Åò„ÇÉ„Å£„Å¶„ÅÑ„Çã„Åø„Åü„ÅÑ„Åß„Åô„Åã„Çâ„Å≠„ÄÇ„Å™„Çì„ÅßÊäó„Ç¶„Ç§„É´„Çπ‰ΩúÁî®„Å†„Åë„Å´Êãò„Çã„ÅÆ„Åã„Å®„ÄÇ https://t.co/OfUMmpph22
"@cameronks @MiscSusan 3/ An interesting medication might be ciclesonide (Alvesco). This is anti-viral and anti-inflammatory. ""The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15"" https://t.co/FM1tgMsNzk"
@BB45_Colorado @WorldSystem7 Ê≤ªÈ®ìÈÄ≤Ë°å‰∏≠„Å†„Åë„Å©„ÄÅÂàùÊúüÊ≤ªÁôÇ„ÅØ„Ç∑„ÇØ„É¨„ÇΩ„Éã„Éâ„ÅåËâØ„ÅÑÊÑü„Åò„ÄÇ „É¢„É°„Çø„Çæ„É≥„ÅÆÁÇπÈºª„Å®Âê∏ÂÖ•„ÇÇ„ÄÇ „Éä„Çæ„Éç„ÉÉ„ÇØ„ÇπÁÇπÈºªÊ∞ó‰ºë„ÇÅ„Å´„Å©„ÅäÔºü „Ç¢„É´„Ç≤„Çπ„Éà„É≥„ÄÅ„Éü„Éï„Çß„Éó„É™„Çπ„Éà„É≥„ÅØÁµåÂè£ÈÅøÂ¶äËñ¨ The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15 https://t.co/PCQid668K9 https://t.co/AbpA2l4aq2
@jwillia2 https://t.co/FluMm9dnyV
"RT @Fraslin: Le Singulair je ne sais pas, mais le cicl√©sonide inhal√© bloquerait la r√©plication de l'ARN du coronavirus en ciblant le NSP15‚Ä¶"
"@Gor316 heb je al gehoord hoe ciclesonide (Alvesco) anti-viraal werkt specifiek voor corona virus? ""The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication"" #corona #Coronavirusnl Zie deze (nog niet peer reviewed) paper: https://t.co/FM"
"RT @KaplanBen_Fr: Autre piste en cours, √©galement prescrit dans les crises d'asthmes, le ciclesonide (Alvesco) qui a une activit√© anti-infl‚Ä¶"
@raoult_didier https://t.co/J3aUIu3Hcg
"@Comparativist And this is quite far-fetched and has no data to do with anything at hand. I still can't find the graphs, but here is some more hard data. I am by no means against quarantines. I locked myself down about a week after Wuhan did. https://t"
"Contribute a rapid review or request one for ""Emergence of RBD mutations in circulating SARS-CoV-2 strains enhancing the structural st..."" (https://t.co/HoSYwJRIXE). ""Add"" or ""Request"" w/DOI (10.1101/2020.03.15.991844) at https://t.co/RnurTL3DyM @outbreaks"
Updated #SARSCoV preprint: Emergence of RBD mutations in circulating SARS-CoV-2 strains enhancing the structural stability and human ACE2 receptor affinity of the spike protein https://t.co/HoSYwJRIXE
RT @johnleremainer: @JeanneBartram @Forbes Research (as yet unpublished) suggests the source more likely to have been pangolins than bats.‚Ä¶
Updated #COVID19 preprint: Emergence of RBD mutations in circulating SARS-CoV-2 strains enhancing the structural stability and human ACE2 receptor affinity of the spike protein https://t.co/HoSYwJRIXE
@JeanneBartram @Forbes Research (as yet unpublished) suggests the source more likely to have been pangolins than bats. Cambridge group have traced earlier mutations to Malaysia and Singapore. https://t.co/gpWgKflN4B
Update on COVID-19 mutation research. NB This pre-publication and has not been peer reviewed https://t.co/gpWgKf4cd3
RT @AB_Algaissi: ÿØÿ±ÿßÿ≥ÿ© ŸáÿßŸÖÿ© ÿπŸÜ ŸÖÿ±ÿ∂Ÿäÿ© ŸÅŸäÿ±Ÿàÿ≥ ŸÉŸàÿ±ŸàŸÜÿß ÿßŸÑÿ¨ÿØŸäÿØ (ÿ≥ÿßÿ±ÿ≥Ÿ¢): ÿ™ÿ≠ŸÑŸäŸÑ ŸÑÿ£ÿπÿ∂ÿßÿ° ÿ¨ÿ≥ŸÖ ÿßŸÑÿ•ŸÜÿ≥ÿßŸÜ ŸÑÿ£ÿ¥ÿÆÿßÿµ ŸÖÿ™ŸàŸÅŸäŸÜ ÿ®ÿßŸÑŸÅŸäÿ±Ÿàÿ≥ÿå Ÿàÿ¨ÿØ ÿ£ŸÜ ÿßŸÑŸÅŸäÿ±Ÿàÿ≥ Ÿäÿ≥ÿ™ŸáÿØŸÅ ÿßŸÑ‚Ä¶
"Contribute a rapid review or request one for ""Emergence of RBD mutations from circulating SARS-CoV-2 strains with enhanced structural ..."" (https://t.co/HoSYwJRIXE). ""Add"" or ""Request"" w/DOI (10.1101/2020.03.15.991844) at https://t.co/RnurTL3DyM @outbreaks"
Updated #SARSCoV preprint: Emergence of RBD mutations from circulating SARS-CoV-2 strains with enhanced structural stability and higher human ACE2 receptor affinity of the spike protein https://t.co/HoSYwJRIXE
@RobertLKruse The experimental validation has been performed in the latest revision: https://t.co/L9hcx9oUgZ
ÿØÿ±ÿßÿ≥ÿ© ŸáÿßŸÖÿ© ÿπŸÜ ŸÖÿ±ÿ∂Ÿäÿ© ŸÅŸäÿ±Ÿàÿ≥ ŸÉŸàÿ±ŸàŸÜÿß ÿßŸÑÿ¨ÿØŸäÿØ (ÿ≥ÿßÿ±ÿ≥Ÿ¢): ÿ™ÿ≠ŸÑŸäŸÑ ŸÑÿ£ÿπÿ∂ÿßÿ° ÿ¨ÿ≥ŸÖ ÿßŸÑÿ•ŸÜÿ≥ÿßŸÜ ŸÑÿ£ÿ¥ÿÆÿßÿµ ŸÖÿ™ŸàŸÅŸäŸÜ ÿ®ÿßŸÑŸÅŸäÿ±Ÿàÿ≥ÿå Ÿàÿ¨ÿØ ÿ£ŸÜ ÿßŸÑŸÅŸäÿ±Ÿàÿ≥ Ÿäÿ≥ÿ™ŸáÿØŸÅ ÿßŸÑÿ∑ÿ≠ÿßŸÑ ŸàÿßŸÑÿπŸÇÿØ ÿßŸÑŸÑŸÖŸÅÿßŸàŸäÿ© (ÿ®ÿßŸÑÿ•ÿ∂ÿßŸÅÿ© ŸÑŸÑÿ±ÿ¶ÿ© ÿ∑ÿ®ÿπÿßŸã) ŸàŸäÿ§ÿ´ÿ± ÿπŸÑŸâ ÿßŸÑÿÆŸÑÿßŸäÿß ÿßŸÑŸÖŸÜÿßÿπŸäÿ©! ÿØŸÑŸäŸÑ ÿπŸÑŸâ ÿ¥ÿØÿ© ŸÖÿ±ÿ∂Ÿäÿ© ÿßŸÑŸÅŸäÿ±Ÿàÿ≥ Ÿàÿ™ÿ£ÿ´Ÿäÿ±Ÿá ÿπŸÑŸâ ÿßŸÑÿ¨Ÿáÿßÿ≤ ÿßŸÑŸÖŸÜÿßÿπŸä. https:
"By now, many strains of mutating SARS-CoV-2 are circulating & still the machinery is on.. Designing a single vaccine for all the strains is only possible with permutation analysis of viral genome. Computational mixture of synthetic mRNA vaccine is an"
@NesrinOzoren @DrudeJacki @ScienceAsk @Nothernlight4 @lexcausatiff https://t.co/xaEVORgkwI
Receptor Binding Domain (RBD) mutations of circulating SARS-CoV-2 strains enhance the structure stability and infectivity of the spike protein. @ICMRDELHI @IndiaDST @DRDO_India https://t.co/4Cv1dClJSS
Maybe take it with a grain of salt but more info on this is needed. https://t.co/LDBpIzSCiE
@firefoxx66 Got some surprising COVID-19 data and trying to submit it to Eurosurveillance and let more people aware. More data than this version have been added. https://t.co/ckuDrammDr
@RolandBakerIII @Lizarazzooo https://t.co/jxbJYnYdnq
RT @skathire: @trvrb Note: paper below claims new mutations in the RBD binding domain have yielded higher affinity binding to ACE2 receptor‚Ä¶
RT @yoshipatho: „Å°„Å™„Åø„Å´„ÄÅ‰∏≠ÂõΩ„ÅÆ„ÉÅ„Éº„É†„Åã„Çâ„ÅÆÂ†±Âëä„ÄÇ È¶ôÊ∏Ø„Åß1Ê†™Ôºã„Éï„É©„É≥„Çπ„Åß4Ê†™„Å´ÂÖ±ÈÄö„Åó„Å¶Ë¶ã„Å§„Åã„Å£„ÅüÂ§âÁï∞„ÅØ„ÄÅACE2„Å®„ÅÆÁµêÂêàÂäõ„ÅåÂ§ßÂπÖ„Å´Âº∑„Åæ„Å£„Å¶„ÅÑ„Çã„Å®„ÄÇ„Åì„Çå„Çâ„ÅØ‰ºùÊí≠ÂÑ™‰ΩçÊÄß„ÇíÁç≤Âæó„Åó„ÅüÂèØËÉΩÊÄß„ÇíÁ§∫ÂîÜ„Åô„Çã„Å®„ÄÇ bioRxiv„Å´„Å§„Åç„É¨„Éì„É•„ÉºÁÑ°„Åó„Å´Ê≥®ÊÑè„ÄÇ https://t‚Ä¶
RT @sanxiyn: @trvrb What do you think of this preprint which suggests V367F is functional? It looks pretty convincing to me. https://t.co/A‚Ä¶
„Å°„Å™„Åø„Å´„ÄÅ‰∏≠ÂõΩ„ÅÆ„ÉÅ„Éº„É†„Åã„Çâ„ÅÆÂ†±Âëä„ÄÇ È¶ôÊ∏Ø„Åß1Ê†™Ôºã„Éï„É©„É≥„Çπ„Åß4Ê†™„Å´ÂÖ±ÈÄö„Åó„Å¶Ë¶ã„Å§„Åã„Å£„ÅüÂ§âÁï∞„ÅØ„ÄÅACE2„Å®„ÅÆÁµêÂêàÂäõ„ÅåÂ§ßÂπÖ„Å´Âº∑„Åæ„Å£„Å¶„ÅÑ„Çã„Å®„ÄÇ„Åì„Çå„Çâ„ÅØ‰ºùÊí≠ÂÑ™‰ΩçÊÄß„ÇíÁç≤Âæó„Åó„ÅüÂèØËÉΩÊÄß„ÇíÁ§∫ÂîÜ„Åô„Çã„Å®„ÄÇ bioRxiv„Å´„Å§„Åç„É¨„Éì„É•„ÉºÁÑ°„Åó„Å´Ê≥®ÊÑè„ÄÇ https://t.co/rgPn4ztv7V
@trvrb What do you think of this preprint which suggests V367F is functional? It looks pretty convincing to me. https://t.co/AKcZuRvuWc
"@Tigress58774042 @squigmater @VGKnightinArmor And viola, it mutated to more effectively bond with ace 2 receptors. https://t.co/0N6Hzcx3UH"
"@truthseeker8487 @VGKnightinArmor @bothhahaandsad Why don't we discuss this little revelation and see how it applies to your ""flu"" theory https://t.co/0N6Hzcx3UH"
RT @sanxiyn: @BrianPardy @RELenski You may want to check out https://t.co/AKcZuRvuWc
Very happy to have interpreted this among a very few initially and partially author the Reservior section on Wikipedia entry for SARS-CoV-2. 70 days ago. https://t.co/oJE9ZjeE7d
@BrianPardy @RELenski You may want to check out https://t.co/AKcZuRvuWc
Updated #SARSCoV preprint: RBD mutations from circulating SARS-CoV-2 strains enhance the structural stability and human ACE2 affinity of the spike protein https://t.co/HoSYwJRIXE
"Contribute a rapid review or request one for ""RBD mutations from circulating SARS-CoV-2 strains enhance the structural stability and h..."" (https://t.co/HoSYwJRIXE). ""Add"" or ""Request"" w/DOI (10.1101/2020.03.15.991844) at https://t.co/RnurTL3DyM @outbreaks"
Updated #COVID19 preprint: RBD mutations from circulating SARS-CoV-2 strains enhance the structural stability and human ACE2 affinity of the spike protein https://t.co/HoSYwJRIXE
Studio evidenzia questo aspetto. https://t.co/UcwczCBo1Z
RT @ambers876: @CurlyJungleJake @A3__BusDriver Check this out. https://t.co/C6HXYsR3FB
@CurlyJungleJake @A3__BusDriver Check this out. https://t.co/C6HXYsR3FB
RT @Karmasura: The virus is getting more potent with tighter coupling with its receptor and can lead to deadlier infections if no precautio‚Ä¶
RT @RobertLKruse: Mutations in Receptor Binding Domain of #SARSCoV2 have been found leading to enhanced ACE2 affinity (100X) & likely infec‚Ä¶
https://t.co/ckuDrammDr
RT @johnleremainer: @EmperorBlargus @historydude6 @Yamiche Paper on the mutation history so far. Bear in mind this paper is being updated a‚Ä¶
@EmperorBlargus @historydude6 @Yamiche Paper on the mutation history so far. Bear in mind this paper is being updated and has not yet been subjected to peer review. They seem to have isolated 18 mutations so far. https://t.co/gpWgKf4cd3
@OSEIMMUNO And do not forget to answer my question in Relation to Tedopi and #COVID19 #coronavirus HLa-A2 mHC allele T cell epitodes looks like we could have something üòé https://t.co/WAsjm3kZHa
"""... #SARS-CoV-2 is able to bind to the same receptor as SARS-CoV (ACE2) for cell entry, despite having multiple amino acid differences with SARS-CoV‚Äôs receptor-binding motif"" #Vaccine bioRxiv viewer https://t.co/gRNureUIys"
medRxiv & bioRxiv: Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies: The beginning of 2020 has seen the emergence of COVID-19 outbreak caused by a novel‚Ä¶ https://t.co/D5HaJzuvDw #coronavirus
https://t.co/4CWe8OkD8G https://t.co/U3KjJVEjlN https://t.co/C7PQWXNezm https://t.co/XOpysfPUBQ
RT @pmarsupia: Nuevo art√≠culo cient√≠fico --> Ideas para desarrollar una vacuna frente al coronavirus. Es incre√≠ble a la velocidad que est√°‚Ä¶
RT @PhyIis: Preliminary identification of potential #vaccine targets for the #COVID_19 #coronavirus (#SARSCoV2) based on SARS-CoV immunolog‚Ä¶
Updated #SARSCoV preprint: Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies https://t.co/aAQHJ7XOeE
"Contribute a rapid review or request one for ""Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SA..."" (https://t.co/aAQHJ7XOeE). ""Add"" or ""Request"" w/DOI (10.1101/2020.02.03.933226) at https://t.co/RnurTKM2ac @outbreaks"
Updated #COVID19 preprint: Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies https://t.co/aAQHJ7XOeE
Preliminary identification of potential #vaccine targets for the #COVID_19 #coronavirus (#SARSCoV2) based on SARS-CoV immunological studies https://t.co/zX7uQzHRag #2019_nCov T Cell Vaccine Candidates Data and Code : https://t.co/tGrfbExfGK #COVID2019
Vaccine targets for 2019-nCoV based on SARS-CoV studies. Epitopes that can help guide experimental efforts towards the development of vaccines. https://t.co/Z99y5F3aVE #coronavirus #ncov2019 #medicine #breaking #fda #cdc #genetics #science #research #vacci
Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies https://t.co/78DdNb8mNJ
Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies https://t.co/yV3PAFp95i
Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies https://t.co/BOEngfzANB
RT @PneumoniaWuhan: Vaccine: Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies‚Ä¶
New #SARSCoV preprint: Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies https://t.co/aAQHJ7Gdn6
"Contribute a rapid review or request one for ""Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV ..."" (https://t.co/aAQHJ7Gdn6). ""Add"" or ""Request"" w/DOI (10.1101/2020.02.03.933226) at https://t.co/RnurTL3DyM @outbreaks"
New #2019nCoV preprint: Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies https://t.co/aAQHJ7Gdn6
#MeHaceLlorar #FelizMiercoles Una cerveza para este buen hombre üëá
"Nuevo art√≠culo cient√≠fico --> Ideas para desarrollar una vacuna frente al coronavirus. Es incre√≠ble a la velocidad que est√°n trabajando los investigadores!!!!! Viva la Ciencia, joder. https://t.co/7Slbg45QRq"
PREPRINT ‚ñ∂Ô∏è Preliminary identification of potential vaccine targets for #2019nCoV based on SARS-CoV immunological studies https://t.co/AzkuEGDOok
RT @greg_folkers: .@biorxivpreprint bioRxiv: Preliminary identification of potential #vaccine targets for 2019-nCoV based on #SARS-CoV immu‚Ä¶
Pre print https://t.co/nvgAQxEiRQ
Vaccine: Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies | bioRxiv https://t.co/xnL65qor75 #wuhanpneumonia #coronavirus #nCoV2019
Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies | bioRxiv. #isciii https://t.co/HTpBl9zeHW
"Our inability to invest in more rapid technologies to create effective vaccines and then mass produce them is a huge, in fact, probably our greatest liability. Rather than spending billions of dollars on military weapons we need to invest in our greatest v"
.@biorxivpreprint bioRxiv: Preliminary identification of potential #vaccine targets for 2019-nCoV based on #SARS-CoV immunological studies #nCoV2019 https://t.co/rbqg6khlqC https://t.co/TrbCIgL2bO
"""Our findings provide a screened set of epitopes that can help guide experimental efforts towards the development of vaccines against 2019-nCoV."""
Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies https://t.co/I7kJwLIB7B #bioRxiv
Potential T-cell and B-cell Epitopes of 2019-nCoV https://t.co/BNjBeo4L3H
@StanfordHAI @DrBinSquared Source paper here: https://t.co/nZ6z0TTZiA
@next_pandemic @DrBinSquared Paper here: https://t.co/nZ6z0TTZiA With @DrBinSquared and @Rbaltman
Potential T-cell and B-cell Epitopes of 2019-nCoV https://t.co/pKrIyjgEvj
RT @unignorant: .@DrBinSquared will be presenting our work on vaccine targets for COVID-19 at a live-streaming video conference hosted by @‚Ä¶
You surprise us Ethan. Much support.
Life goals. A researcher and crypto guy.
.@DrBinSquared will be presenting our work on vaccine targets for COVID-19 at a live-streaming video conference hosted by @StanfordHAI on April 1st: https://t.co/LO2j937ctr The stream will be open to everyone! Paper here: https://t.co/6xQNptiK0z
Updated #SARSCoV preprint: Potential T-cell and B-cell Epitopes of 2019-nCoV https://t.co/mGvG90vUNH
"Contribute a rapid review or request one for ""Potential T-cell and B-cell Epitopes of 2019-nCoV"" (https://t.co/mGvG90vUNH). ""Add"" or ""Request"" w/DOI (10.1101/2020.02.19.955484) at https://t.co/RnurTL3DyM @outbreaksci @PREreview_"
Updated #COVID19 preprint: Potential T-cell and B-cell Epitopes of 2019-nCoV https://t.co/mGvG90vUNH
"‚úÖ Probably need a chimeric VLP produced combining multiple epitopes, see HLA type for pop conv once data available. ‚úÖ Look at hydrostatic/MD options from the crystal structure to increase immunogenicity. ‚úÖAfter folding not all are surface expressed htt"
RT @gungulati: Incredible work identifying epitopes for vaccines and antibody-based neutralization of 2019-nCoV by talented friend and coll‚Ä¶
"RT @unignorant: While on vacation last week, @DrBinSquared and I did some work identifying potential T-Cell and B-Cell epitopes in 2019-nCo‚Ä¶"
RT @PromPreprint: Potential T-cell and B-cell Epitopes of 2019-nCoV https://t.co/EHRvWnylMi
Potential T-cell and B-cell Epitopes of 2019-nCoV https://t.co/EHRvWnylMi
New #SARSCoV preprint: Potential T-cell and B-cell Epitopes of 2019-nCoV https://t.co/mGvG90vUNH
New #COVID19 preprint: Potential T-cell and B-cell Epitopes of 2019-nCoV https://t.co/mGvG90vUNH
RT @fstepho: @cz_binance Incredible work identifying epitopes for vaccines and antibody-based neutralization of 2019-nCoV https://t.co/f2o‚Ä¶
@LABeachGal1 Found something positive for a change https://t.co/8K5qlo0M2C
@cz_binance Incredible work identifying epitopes for vaccines and antibody-based neutralization of 2019-nCoV https://t.co/f2oFnaCZiy
RT @biorxivpreprint: Potential T-cell and B-cell Epitopes of 2019-nCoV https://t.co/F9iASpUCFu #bioRxiv
RT @AshAlizadeh: MARIA and friends in action: Potential T-cell and B-cell Epitopes of 2019-nCoV | bioRxiv https://t.co/HZlIz4a0Eo
MARIA and friends in action: Potential T-cell and B-cell Epitopes of 2019-nCoV | bioRxiv https://t.co/HZlIz4a0Eo
"While on vacation last week, @DrBinSquared and I did some work identifying potential T-Cell and B-Cell epitopes in 2019-nCoV (causing COVID-19). No vaccines have yet been approved for any form of coronavirus: https://t.co/ByvmkRjlYK https://t.co/fXrbEbuhOS"
"Incredible work identifying epitopes for vaccines and antibody-based neutralization of 2019-nCoV by talented friend and colleague, Binbin Chen. Immediate and relevant application of the tool he developed in his PhD, MARIA: https://t.co/Vg9mInfoey"
Potential T-cell and B-cell Epitopes of 2019-nCoV https://t.co/LosPYdqbRL
RT @biorxiv_micrbio: Potential T-cell and B-cell Epitopes of 2019-nCoV https://t.co/oyObfHRrLV #biorxiv_micrbio
Potential T-cell and B-cell Epitopes of 2019-nCoV https://t.co/oyObfHRrLV #biorxiv_micrbio
Potential T-cell and B-cell Epitopes of 2019-nCoV https://t.co/F9iASpUCFu #bioRxiv
"@strodellab Its a great effort, looking forward to seeing it online! I am just a tad bit concerned that MPro might not be the target you want in SARS-COV-2 because its active site is quite flexible ( I might be pragmatic here ), you might want to see: http"
Updated #SARSCoV preprint: Structural and Evolutionary Analysis Indicate that the SARS-CoV-2 Mpro is an Inconvenient Target for Small-Molecule Inhibitors Design https://t.co/Ew4S0GDk6x
"Contribute a rapid review or request one for ""Structural and Evolutionary Analysis Indicate that the SARS-CoV-2 Mpro is an Inconvenien..."" (https://t.co/Ew4S0GDk6x). ""Add"" or ""Request"" w/DOI (10.1101/2020.02.27.968008) at https://t.co/RnurTL3DyM @outbreaks"
Updated #COVID19 preprint: Structural and Evolutionary Analysis Indicate that the SARS-CoV-2 Mpro is an Inconvenient Target for Small-Molecule Inhibitors Design https://t.co/Ew4S0GDk6x
"¬´Molecular Dynamics Simulations Indicate the COVID-19 Mpro Is Not a Viable Target for Small-Molecule Inhibitors Design,¬ª bioRxiv (Mar 2020), doi: https://t.co/P30ZOm0QeO."
RT @kmitusinska: Check out our updated preprint on #SARS_COV_2! We used @AQUA_DUCT software and multiple MD simulations #compchem to explor‚Ä¶
"Unfortunately, recent research indicates that the binding pocket of SARS-CoV-2 may be very different from that of other coronaviruses, so previous drugs against those viruses may not work https://t.co/nS4vWLBUse"
We have updated our preprint and we are continuing our effort to win this and future battles! Molecular Dynamics Simulations Indicate the SARS-CoV-2 Mpro Is Not a Viable Target for Small-Molecule Inhibitors Design https://t.co/JyOM2aqhW9
Check out our updated preprint on #SARS_COV_2! We used @AQUA_DUCT software and multiple MD simulations #compchem to explore the internal cavity of this #protein. Hope you find it helpful!
Updated #SARSCoV preprint: Molecular Dynamics Simulations Indicate the SARS-CoV-2 Mpro Is Not a Viable Target for Small-Molecule Inhibitors Design https://t.co/Ew4S0GDk6x
"Contribute a rapid review or request one for ""Molecular Dynamics Simulations Indicate the SARS-CoV-2 Mpro Is Not a Viable Target for S..."" (https://t.co/Ew4S0GDk6x). ""Add"" or ""Request"" w/DOI (10.1101/2020.02.27.968008) at https://t.co/RnurTL3DyM @outbreaks"
Updated #COVID19 preprint: Molecular Dynamics Simulations Indicate the SARS-CoV-2 Mpro Is Not a Viable Target for Small-Molecule Inhibitors Design https://t.co/Ew4S0GDk6x
RT @influenzer3: SARS-CoV„Å®SARS-CoV-2„ÅÆprotease„ÅÆÁ´ã‰ΩìÊßãÈÄ†„ÅØÂÖ®„ÅèÁï∞„Å™„Çã„Å®„ÅÑ„ÅÜÂ†±Âëä„ÄÇÈÅ∫‰ºùÂ≠êÁöÑ„Å™È°û‰ººÊÄß„Å´„ÇÇÈñ¢„Çè„Çâ„Åö„Éù„Ç±„ÉÉ„Éà„ÅÆÁ´ã‰ΩìÊßãÈÄ†„ÅåÁï∞„Å™„Çã„ÅÆ„Åß„ÄÅSARS„Å´„ÅØÊúâÂäπ„Åß„ÇÇCOVID-19„Å´„ÅØÁÑ°Âäπ„Å™„ÅÆ„Åß„ÅØ„Å™„ÅÑ„Åã„Å®„ÄÇÊú¨Êñá„Å´ÊòéÁ§∫„Åï„Çå„Å¶„ÅÑ„Åæ„Åõ„Çì„Åå„ÄÅ„Ç´„É¨‚Ä¶
How @AQUA_DUCT can be used to fight with #COVID„Éº19? Learn more: Molecular Dynamics Simulations Indicate the COVID-19 Mpro Is Not a Viable Target for Small-Molecule Inhibitors Design https://t.co/COu1ZKt9tg and register for Summer School only 10 days left h
SARS-CoV„Å®SARS-CoV-2„ÅÆprotease„ÅÆÁ´ã‰ΩìÊßãÈÄ†„ÅØÂÖ®„ÅèÁï∞„Å™„Çã„Å®„ÅÑ„ÅÜÂ†±Âëä„ÄÇÈÅ∫‰ºùÂ≠êÁöÑ„Å™È°û‰ººÊÄß„Å´„ÇÇÈñ¢„Çè„Çâ„Åö„Éù„Ç±„ÉÉ„Éà„ÅÆÁ´ã‰ΩìÊßãÈÄ†„ÅåÁï∞„Å™„Çã„ÅÆ„Åß„ÄÅSARS„Å´„ÅØÊúâÂäπ„Åß„ÇÇCOVID-19„Å´„ÅØÁÑ°Âäπ„Å™„ÅÆ„Åß„ÅØ„Å™„ÅÑ„Åã„Å®„ÄÇÊú¨Êñá„Å´ÊòéÁ§∫„Åï„Çå„Å¶„ÅÑ„Åæ„Åõ„Çì„Åå„ÄÅ„Ç´„É¨„Éà„É©„Å™„Å©„ÅÆÊäóHIVËñ¨„ÅÆ‰∫ã„ÇíËø∞„Åπ„Å¶„ÅÑ„Çã„Å®ÊÄù„Çè„Çå„Åæ„Åô„ÄÇ https://t.co/cCBpa2HctI
RT @a_chtung: –ü–æ–∫–∞ –≤ –∑–∞–∫–ª–∞–¥–∫–∏: https://t.co/0V9un8tRTT
@influenzer3 https://t.co/i0Xlmlf7ea „Ç¢„É°„É™„Ç´„ÄÅÊ§úÊüªÊï∞„ÇíÈùûÈñãÁ§∫Ôºü https://t.co/NMN5gft2F0 Ê¥ªÊÄßÈÉ®‰Ωç„ÅÆÂΩ¢Áä∂„ÅåSARS„Å®ÈÅï„ÅÜ„Åü„ÇÅ„ÄÅÂâµËñ¨„Çø„Éº„Ç≤„ÉÉ„Éà„Åå‰ªä„ÅÆ„Åß„ÅØËâØ„Åè„Å™„ÅÑ„ÅÆ„Åß„ÅØÔºü„Å®„ÅÑ„ÅÜË´ñÊñáÔºà„Çâ„Åó„ÅÑÔºâ„Åß„Åô„ÄÇ https://t.co/GvZeJ5A9FU ÁèæÂ†¥„ÅÆË©±„ÄÇÂÖàÁîü„ÅÆÊâÄ„ÅØ„Åì„ÅÆ„Çà„ÅÜ„Å™Êñπ„ÅØÊù•„Çâ„Çå„Å¶„Å™„ÅÑ„Åß„Åó„Çá„ÅÜ„ÅãÔºü
Molecular Dynamics Simulations Indicate the COVID-19 Mpro Is Not a Viable Target for Small-Molecule Inhibitors Design https://t.co/twBZkQiCF4
„Åì„Çå„Å£„Å¶SARS-CoV-2„ÅÆÊåôÂãï„ÅØSARS„Å®„ÅØÂÖ®„ÅèÂà•Áâ©„Å´„Å™„Çã„Å®„ÅÑ„ÅÜÁêÜËß£„Åß„ÅÑ„Åä„ÅÆ„Å†„Çç„ÅÜ„ÅãÔºüËÖéËáì„Å®„Åã„Å´ÂØæ„Åô„ÇãÊîªÊíÉ„ÅØÁÑ°„ÅÑ„Å®ÊÄù„Å£„Å¶„ÅÑ„ÅÑ„ÅÆ„Åã„Å™Ôºü https://t.co/Gl90s45PHq
RT @BzowkaMaria: Check this out! Our study on #COVID19 and #SARS main proteases using classical and mixed-solvent #moleculardynamics simula‚Ä¶
RT @iina_kobe: Molecular Dynamics Simulations Indicate the COVID-19 Mpro Is Not a Viable Target for Small-Molecule Inhibitors Design | bioR‚Ä¶
Molecular Dynamics Simulations Indicate the COVID-19 Mpro Is Not a Viable Target for Small-Molecule Inhibitors Design | bioRxiv ÊäóÂéüË™çË≠ò„Åï„Çå„Åö„Å´ÊΩú‰ºè„Åß„Åç„Çã„Çí„ÇÑ„Åã„Çâ„Çè„Åã„Å£„Å¶„Åü‰∫ã„Åß„ÅØ„ÄÇ„ÄÇ„ÄÇ https://t.co/neX5Sfl25m
RT @HattoriM: SARS-CoV-2„Å®SARS„ÅÆMpro„ÅÆMD„Çí„ÇÑ„Å£„ÅüÊÑü„Åò„ÄÅÈÖçÂàó„ÅØ„Åª„ÅºÂêå„Åò„Å™„ÅÆ„Å´Ê¥ªÊÄßÈÉ®‰Ωç„ÅÆÂΩ¢Áä∂„ÅåÂâ≤„Å®ÈÅï„ÅÜÊÑü„Åò„Åß„ÄÅÁâπ„Å´SARS-CoV-2„ÅÆ„ÅØÊ¥ªÊÄßÈÉ®‰Ωç„Åå„Éï„É©„Éï„É©„Åó„Å¶„Åä„ÇäÂâµËñ¨„Çø„Éº„Ç≤„ÉÉ„Éà„Å®„Åó„Å¶SARS-CoV-2 Mpro„ÅØÁ≠ãÊÇ™„Åß„ÅØ„Å™„ÅÑ„ÅãÔºü„Å®„ÅÆ‰∏ªÂºµ„ÅÆBio‚Ä¶
RT @biorxivpreprint: Molecular Dynamics Simulations Indicate the COVID-19 Mpro Is Not a Viable Target for Small-Molecule Inhibitors Design‚Ä¶
"Contribute a rapid review or request one for ""Molecular Dynamics Simulations Indicate the COVID-19 Mpro Is Not a Viable Target for Sma..."" (https://t.co/Ew4S0GDk6x). ""Add"" or ""Request"" w/DOI (10.1101/2020.02.27.968008) at https://t.co/RnurTL3DyM @outbreaks"
New #COVID19 preprint: Molecular Dynamics Simulations Indicate the COVID-19 Mpro Is Not a Viable Target for Small-Molecule Inhibitors Design https://t.co/Ew4S0GDk6x
Check this out! Our study on #COVID19 and #SARS main proteases using classical and mixed-solvent #moleculardynamics simulations We are fighting against #coronavirus as well #compchem #Covid_19
Here is our contribution to the fight against novel #coronavirus #COVD19 Check what do the #moleculardynamics results tell us Hope you find it useful! #compchem #SARSCoV2
"Our small contribution, we hope it will be helpful. @tunnelinggroup @AQUA_DUCT"
https://t.co/OlZpjwsIqt
bioArXiv_ Molecular Dynamics Simulations Indicate the COVID-19 Mpro Is Not a Viable Target for Small-Molecule Inhibitors Design https://t.co/vt3fEAkxYl
Molecular Dynamics Simulations Indicate the COVID-19 Mpro Is Not a Viable Target for Small-Molecule Inhibitors Design https://t.co/i5o4dJj39G
Molecular Dynamics Simulations Indicate the COVID-19 Mpro Is Not a Viable Target for Small-Molecule Inhibitors Design https://t.co/czlcvJ2Jrp #bioRxiv
@RepMeuser @WhiteHouse @realDonaldTrump It kind of looks like Trump is the reason we have coronavirus. It's from Taiwan: https://t.co/EPPyT326ya US Taiwan Assurance Act: Cotton (R-Ark) & Trump gave Taiwan biological weapons:
"@arambaut @bioinformAnt @daanensen @AineToole @viralverity @McCroneIV Please look at Bhattacharjee (https://t.co/EPPyT326ya ) - ancestral virus from Taiwan. And - Taiwan Assurance Act of 2019, including early drafts. ""Deliver military articles"" for ""asym"
"@K_G_Andersen @reddit Dr. Andersen... https://t.co/D7bIctUITD ""Only viral genome sequence identified from Taiwan entry does not show any mutation, suggesting this is the ancestral genome sequence."""
@Salon I always laugh when people mock conspiracy theories. Even the worst theory still means someone was *thinking*. And this one's easy. The conspiracy is an obvious one: NATO. 1. Taiwan dropped it: https://t.co/EPPyT326ya 2. We gave it to them:
"RT @nanogenomic: @EricTopol @13pt @carlzimmer @NYTScience ""Transition from C to T (C>T) is the most frequent mutation in this viral genome‚Ä¶"
"@JoeUscinski Or Bhattacharjee: https://t.co/D7bIctUITD ""1) Only viral genome sequence identified from Taiwan entry does not show any mutation, suggesting this is the ancestral genome sequence."""
"@SethAbramson Trump didn't make the virus, your Deep State boys did. https://t.co/D7bIctUITD Look, it's not even from Wuhan. It's from Taiwan."
"@EricTopol @13pt @carlzimmer @NYTScience ""Transition from C to T (C>T) is the most frequent mutation in this viral genome and mutations A>T, G>A, T>A are the rarest ones, found in countries with maximum fatality rate i.e Italy, Spain and Sweden"
RT @PromPreprint: Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and‚Ä¶
Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and evolutionary divergence https://t.co/pU9OZUkRJw
Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and evolutionary divergence https://t.co/Q7ZFSLIVhY
Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and evolutionary divergence https://t.co/NTNkTAlU14
"RT @Luca_Mussati: @GreatGameIndia @Nonnepossopi1 Your researchers instead correlate the higher lethality of Italy, Spain and Sweden with di‚Ä¶"
RT @nanogenomic: @Problemofinduc @bitcoinbopulos @naval ‚ÄúThe lethality of different viral strains is found to vary in different geographica‚Ä¶
@naval https://t.co/IaxQ5UjxZz
"RT @nanogenomic: @Problemofinduc @bitcoinbopulos @naval Obviously, the lethality of every strain has not been determined yet. There are con‚Ä¶"
"@Problemofinduc @bitcoinbopulos @naval ‚ÄúThe lethality of different viral strains is found to vary in different geographical locations...‚Äù ‚Äú...mutations A>T, G>A, T>A are the rarest ones, found in countries with maximum fatality rate i.e Italy, Sp"
#NAME?
RT @Luca_Mussati: Le variazioni di letalit√† geografiche possono essere dovute a mutazioni del virus + o - aggressive. I ceppi + letali son‚Ä¶
"@GreatGameIndia @Nonnepossopi1 Your researchers instead correlate the higher lethality of Italy, Spain and Sweden with different virus strains. https://t.co/AF20NI4ybi https://t.co/AFkdXDQTwl"
@udogumpel Forse invece perch√© in Italia abbiamo un ceppo pi√π letale https://t.co/AF20NI4ybi https://t.co/xOywKDhFFO
Le variazioni di letalit√† geografiche possono essere dovute a mutazioni del virus + o - aggressive. I ceppi + letali sono in ItaüáÆüáπ Espüá™üá∏ Sveüá∏üá™ Si distinguono 4 ceppi: ‚ûñestremamente letale (E) ‚ûñletale (L) ‚ûñnon letale (S) ‚ûñintermedio (I). #Covid_19 https:/
RT @ShuvamBanerje18: Thank you for sharing @biorxivpreprint https://t.co/u1MB7LFsre
"""The lethality of different viral strains is found to vary in different geographical locations but the molecular mechanism is yet to be known"". We are eager to know!!!"
RT @biorxivpreprint: Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis a‚Ä¶
RT @AISFofficial: The research paper can be accessed by visiting Bioprxiv... Decoding the lethal effect of SARS-CoV-2 (novel coronavirus)‚Ä¶
#bioRxiv Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and evolutionary divergence #bioinfo https://t.co/EB6sD0fUCH
RT @ShuvamBanerje18: Thank you for sharing @biorxivpreprint
"ùóßùó∂ùòÅùóπùó≤: Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and evolutionary divergence. ùóîùòÇùòÅùóµùóºùóøùòÄ: Banerjee, S.; Dhar, S.; Bhattacharjee, S.; Bhattacharjee, P. https://t.co/uhD8CsyPCf https://t"
The research paper can be accessed by visiting Bioprxiv... Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and ... https://t.co/t5ktkzG8Ua #biorxiv_bioinfo #AISF
Thank you for sharing @biorxivpreprint
RT @biorxiv_bioinfo: Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis a‚Ä¶
Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and evolutionary divergence https://t.co/E88hJi6f2W
New #SARSCoV preprint: Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and evolutionary divergence https://t.co/iNN6oojKm9
"Contribute a rapid review or request one for ""Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspec..."" (https://t.co/iNN6oojKm9). ""Add"" or ""Request"" w/DOI (10.1101/2020.04.06.027854) at https://t.co/RnurTL3DyM @outbreaks"
New #COVID19 preprint: Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and evolutionary divergence https://t.co/iNN6oojKm9
RT @lucasllach: The fatality outcome depends on three important factors (a) number of mutation (b) rarity of the allelic variation and (c)‚Ä¶
Sars-CoV-2'nin farklƒ± coƒürafyalarda bulunan farklƒ± √∂l√ºmc√ºl y√ºzdelere sahip √∂rneklerinin evrimsel analizi. https://t.co/fDkS5CxvHp
The fatality outcome depends on three important factors (a) number of mutation (b) rarity of the allelic variation and (c) functional consequence of the mutation at protein level. https://t.co/lsHcPZU7He
RT @Vitalintegrity: @LouDobbs @mikepillsbury @realDonaldTrump Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from glo‚Ä¶
Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and evolutionary divergence https://t.co/7A2Jyr0f82
@LouDobbs @mikepillsbury @realDonaldTrump Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and evolutionary divergence https://t.co/a7QM6gnBgd https://t.co/wAZoQoqR2X
Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and evolutionary divergence https://t.co/IJyW42BS4b #glycotime
RT @SciArt3D: SARS-CoV-2 ü¶†üß¨üò∑about molecular pathogenesis and evolutionary divergence | bioRxiv https://t.co/kIFUXW6viu
SARS-CoV-2 ü¶†üß¨üò∑about molecular pathogenesis and evolutionary divergence | bioRxiv https://t.co/kIFUXW6viu
Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and evolutionary divergence https://t.co/cEdZWPBwCd
Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and ... https://t.co/CZeQHpKP8U #biorxiv_bioinfo
Decoding the lethal effect of SARS-CoV-2 (novel coronavirus) strains from global perspective: molecular pathogenesis and evolutionary divergence https://t.co/c8dorjiAC2 #bioRxiv
"Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism [NEW RESULTS] https://t.co/C2f6mbNxGY"
"Updated #SARSCoV preprint: Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism https://t.co/0hCCCM3Rmo"
"Contribute a rapid review or request one for ""Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: similarity with SARS-CoV..."" (https://t.co/0hCCCM3Rmo). ""Add"" or ""Request"" w/DOI (10.1101/2020.03.04.976027) at https://t.co/RnurTL3DyM @outbreaks"
"Updated #COVID19 preprint: Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism https://t.co/0hCCCM3Rmo"
"RT @glycopreprint: Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: similarity with SARS-CoV, hot-spot analysis and effect o‚Ä¶"
"Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism https://t.co/fguKKZ4H9H #glycotime"
"RT @spiderspapers: In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARS-CoV, hot-spot analysis‚Ä¶"
"RT @biorxiv_bioinfo: In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARS-CoV, hot-spot analysi‚Ä¶"
RT @houcemoo: Our new paper about SARS-CoV-2 In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SA‚Ä¶
RT @houcemoo: SecoA secondnd version of the preprint #SARSCoV @biorxiv_bioinfo 'Interaction of the spike protein RBD from SARS-CoV-2 with A‚Ä¶
"RT @outbreaksci: Updated #COVID19 preprint: Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: similarity with SARS-CoV, hot-s‚Ä¶"
"RT @biorxivpreprint: In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARS-CoV, hot-spot analysi‚Ä¶"
RT @antibodies_ol: CoV-2 Protein Interactome (https://t.co/5QUDYrEn9G) turns protein interactions into action like for the one described in‚Ä¶
#UconnBigDataBiology
CoV-2 Protein Interactome (https://t.co/5QUDYrEn9G) turns protein interactions into action like for the one described in https://t.co/a6ZCZsgpRL
"SecoA secondnd version of the preprint #SARSCoV @biorxiv_bioinfo 'Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism' has been submitted https://t.co/ACKuZWfw"
"RT @ian_hoffecker: In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARS-CoV, hot-spot analysis‚Ä¶"
#covid19 developments from research perspective https://t.co/HnKtVyCnCg
"Updated #SARSCoV preprint: In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism https://t.co/0hCCCM3Rmo"
"Contribute a rapid review or request one for ""In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity w..."" (https://t.co/0hCCCM3Rmo). ""Add"" or ""Request"" w/DOI (10.1101/2020.03.04.976027) at https://t.co/RnurTL3DyM @outbreaks"
"Updated #COVID19 preprint: In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism https://t.co/0hCCCM3Rmo"
RT @CRGenomica: Ahora FoldX se usa para ver c√≥mo ACE2 interact√∫a con prote√≠nas de la superf√≠cie de #COVID19. ACE2 es un receptor de c√©lulas‚Ä¶
"A ma connaissance, premier travail scientifique sur #covid19 incluant des tunisiens sur la plateforme @biorxiv_pubd. Attention, ce travail n'est pas encore une publication review√©e par des pairs mais encore un draft. https://t.co/Dtq5IaUIi9"
Ahora FoldX se usa para ver c√≥mo ACE2 interact√∫a con prote√≠nas de la superf√≠cie de #COVID19. ACE2 es un receptor de c√©lulas sospechoso de ser via de entrada del virus a la c√©lula huesped. Entender este proceso es clave para el diagn√≥stico y tratamiento. h
Ara FoldX s'utilitza per veure com ACE2 interactua amb prote√Ønes a la superf√≠cie de #COVID19. ACE2 √©s un dels receptors de c√®l¬∑lules sospit√≥s de ser via d'entrada del virus a la c√®l¬∑lula hoste. Comprendre aquest proc√©s √©s clau pel diagn√≤stic i tractament.
RT @CRGenomica: Now FoldX is being used to test how ACE2 interacts with proteins on surface of #COVID19. ACE2 is one of the suspected cell‚Ä¶
Now FoldX is being used to test how ACE2 interacts with proteins on surface of #COVID19. ACE2 is one of the suspected cell receptors via which the virus invades a host cell. Understanding this process is key for diagnostics and treatment. https://t.co/m5c
"In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism https://t.co/elH1s98DYC"
Excellent work Houcemeddine !
In silico study of the spike protein from SARS-CoV-2 interaction with ACE2
"New #SARSCoV preprint: In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism https://t.co/0hCCCM3Rmo"
"New #COVID19 preprint: In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism https://t.co/0hCCCM3Rmo"
üáπüá≥
"Our new paper about SARS-CoV-2 In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism https://t.co/qf1f9tFmA2"
"#bioRxiv In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism #bioinfo https://t.co/R6qj801KWR"
"In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism https://t.co/WKiJLLNxko"
was wondering about this today. reminds me of the WWII planes and how they figured out where to put the armor...
"In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARS-CoV, hot-spot analysis and effect ... https://t.co/ugO1l5zkh0 #biorxiv_bioinfo"
"In silico study of the spike protein from SARS-CoV-2 interaction with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism https://t.co/SzKuJImSD3 #bioRxiv"
Updated #SARSCoV preprint: Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2 spike protein https://t.co/uv7HSEnsxm
"Contribute a rapid review or request one for ""Computational simulations reveal the binding dynamics between human ACE2 and the recepto..."" (https://t.co/uv7HSEnsxm). ""Add"" or ""Request"" w/DOI (10.1101/2020.03.24.005561) at https://t.co/RnurTL3DyM @outbreaks"
Updated #COVID19 preprint: Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2 spike protein https://t.co/uv7HSEnsxm
RT @biorxivpreprint: Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2‚Ä¶
New #SARSCoV preprint: Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2 spike protein https://t.co/uv7HSEnsxm
New #COVID19 preprint: Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2 spike protein https://t.co/uv7HSEnsxm
üìù Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2 spike protein medRxiv or bioRxiv https://t.co/pyV5QZYu3x #COVID19 #COVID19Papers #SARSCoV2
Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2 spike protein https://t.co/dMnvhukJfR
RT @biorxiv_biophys: Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2‚Ä¶
Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2 spike protein https://t.co/ZoDKT2nTOo #biorxiv_biophys
Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2 spike protein https://t.co/PuHuoMlwLf #bioRxiv
RT @Crispercas20: https://t.co/8jILomRRKf ACE2-Ig„Å†„Åë„ÅßTÁ¥∞ËÉûÊÑüÊüì„ÇíÊäë„Åà„Çâ„Çå„Çã„Åã„Å©„ÅÜ„ÅãË¶ã„Å¶„Åø„Åü„ÅÑ„Åß„Åô„Å≠„ÄÇ293T„Å´ACE2Áô∫Áèæ„Åï„Åõ„ÅüÁ¥∞ËÉû„ÅÆÊÑüÊüì„Éñ„É≠„ÉÉ„ÇØ„Å†„Åë„ÅßË¶ã„Å¶„ÅÑ„Å¶„ÇÇ„Å™„ÅÇ„ÄÇ
RT @biorxivpreprint: Potential host range of multiple SARS-like coronaviruses and an improved ACE2-Fc variant that is potent against both S‚Ä¶
"ùóßùó∂ùòÅùóπùó≤: Potential host range of multiple SARS-like coronaviruses and an improved ACE2-Fc variant that is potent against both SARS-CoV-2 and SARS-CoV-1. ùóîùòÇùòÅùóµùóºùóøùòÄ: Li, Y.; Wang, H.; Tang, X.; Ma, D.; Du, C.; Wang, Y.; Pan, H... https://t.co/FnjyW0Ooy8 https://"
Some one recognizing role of FC receptor #COVID19 : We show that SARS-CoV-2 and SARS-CoV-1 entry could be potently blocked by recombinant IgG Fc-fusion proteins of viral spike protein receptor-binding domains (RBD-Fc) and soluble ACE2 (ACE2-Fc). üòå https:/
New #SARSCoV preprint: Potential host range of multiple SARS-like coronaviruses and an improved ACE2-Fc variant that is potent against both SARS-CoV-2 and SARS-CoV-1 https://t.co/UpT5kbWNRh
"Contribute a rapid review or request one for ""Potential host range of multiple SARS-like coronaviruses and an improved ACE2-Fc variant..."" (https://t.co/UpT5kbWNRh). ""Add"" or ""Request"" w/DOI (10.1101/2020.04.10.032342) at https://t.co/RnurTL3DyM @outbreaks"
New #COVID19 preprint: Potential host range of multiple SARS-like coronaviruses and an improved ACE2-Fc variant that is potent against both SARS-CoV-2 and SARS-CoV-1 https://t.co/UpT5kbWNRh
"RT @CyrilPedia: More ACE2 decoy strategies 'Moreover, an ACE2-Fc variant, which carries a D30E mutation and has ACE2 truncated at its resi‚Ä¶"
RT @biorxiv_micrbio: Potential host range of multiple SARS-like coronaviruses and an improved ACE2-Fc variant that is potent against both S‚Ä¶
"RT @SciArt3D: Estudio sugiere que mol√©culas derivadas conteniendo Fc de Ig, ""RBD-Fc"" y ""ACE2-Fc"", podr√≠an ser herramientas terap√©uticas pa‚Ä¶"
Potential host range of multiple SARS-like coronaviruses and an improved ACE2-Fc variant that is potent against both SARS-CoV-2 and SARS-CoV-1 https://t.co/txdDkwvuN2 RBD-Fc and ACE2-Fc could be used to treat and prevent infection of any new viral variants
"More ACE2 decoy strategies 'Moreover, an ACE2-Fc variant, which carries a D30E mutation and has ACE2 truncated at its residue 740 but not 615, outperforms all the other ACE2-Fc variants on blocking entry of both viruses.' https://t.co/Yh6J2baRKN"
https://t.co/8jILomRRKf ACE2-Ig„Å†„Åë„ÅßTÁ¥∞ËÉûÊÑüÊüì„ÇíÊäë„Åà„Çâ„Çå„Çã„Åã„Å©„ÅÜ„ÅãË¶ã„Å¶„Åø„Åü„ÅÑ„Åß„Åô„Å≠„ÄÇ293T„Å´ACE2Áô∫Áèæ„Åï„Åõ„ÅüÁ¥∞ËÉû„ÅÆÊÑüÊüì„Éñ„É≠„ÉÉ„ÇØ„Å†„Åë„ÅßË¶ã„Å¶„ÅÑ„Å¶„ÇÇ„Å™„ÅÇ„ÄÇ
"https://t.co/zcyqfzH62M In addition to soluble ACE2, RBD-Fc and ACE2-Fc can also possibly block receptor mediated SARS-CoV2 entry."
"Estudio sugiere que mol√©culas derivadas conteniendo Fc de Ig, ""RBD-Fc"" y ""ACE2-Fc"", podr√≠an ser herramientas terap√©uticas para prevenir infecci√≥n por SARS-CoV-2.üëáüëáüëáhttps://t.co/CpyJ7OLk7p"
Potential host range of multiple SARS-like coronaviruses and an improved ACE2-Fc variant that is potent against both SARS-CoV-2 and ... https://t.co/Nk0sFVHxeZ #biorxiv_micrbio
Potential host range of multiple SARS-like coronaviruses and an improved ACE2-Fc variant that is potent against both SARS-CoV-2 and SARS-CoV-1 https://t.co/d8IhZfQsig #bioRxiv
@Cure92 @th2re @annebormans il mute on le sait comme tout virus... Mais la nature est bien faite l plupart du tps le virus mute ds le bon sens pour √©viter justement la mort de son h√¥te sinon il ne peut plus se multiplier. D'o√π ma r√©flexion sur le caract√®re
"""Is mutation in ‚ÄòS‚Äô protein of Indian isolates of #SARSCoV2 #genome responsible for lower #infectivity of virus in #India? Mutations can potentially alter virus entry and thus determine the infectivity."""
Thank you INYAS for sharing our collaborative work.
RT @INYAS_INSA: A virus that has gone viral: Amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact recept‚Ä¶
A virus that has gone viral: Amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding and thus infectivity https://t.co/9Ajo3m05GO @CSIR_IND @shekhar_mande @Sandeep_1966 @IndiaDST #Covid #Covid19 @INYAS_INSA
A virus that has gone viral: Amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding and thus infectivity https://t.co/l8mgcmxr8O
Is mutation in ‚ÄòS‚Äô protein of Indian isolates of #SARSCoV2 genome responsible for lower infectivity of virus in #India? Mutations can potentially alter virus entry and thus determine the infectivity. https://t.co/y35vpC8EYd https://t.co/R8BHOO11bB
RT @DNA_PAPA: „Ç§„É≥„Éâ„ÅßË¶ã„Å§„Åã„Å£„ÅüÊñ∞Âûã„Ç≥„É≠„Éä„Ç¶„Ç£„É´„Çπ„ÅÆ„Ç≤„Éé„É†„ÇíËß£Êûê„Åó„Åü„Å®„Åì„Çç„Çπ„Éë„Ç§„ÇØÈÉ®ÂàÜ„ÅÆDNAÈÖçÂàó„Åå1„Ç´ÊâÄÁ™ÅÁÑ∂Â§âÁï∞„Çí„Åó„Å¶„Åä„Çä„ÄÅ„Åù„ÅÆÁ™ÅÁÑ∂Â§âÁï∞„Åå„Çπ„Éë„Ç§„ÇØÈÉ®ÂàÜ„ÅÆÊßãÈÄ†„ÇíÂ§â„Åà„ÅüÂèØËÉΩÊÄß„Åå„ÅÇ„Çã„Å®„ÅÆ„Åì„Å®„ÄÇ https://t.co/ImupxjkxEo
"@MackayIM @tommyk122 @coastal_nurse @_b_meyer How about that? It's not so hype about failing in vaccine developement, but points out that it might have a impact. https://t.co/5jPrZoyuF1"
El estudio no revisado por pares: https://t.co/u44TzUA4wO
RT @mihaelhp: A new mutation of #SARSCoV2 at position 144 at the Receptor Bindibg Domain of an #Indian isolate differs from viral sequences‚Ä¶
RT @r_trainer: @influenzer3 „ÅäÁñ≤„ÇåÊßò„Åß„Åô„ÄÇÊú¨Êó•„ÅÆÊÉÖÂ†±„Åß„Åô„ÄÇ https://t.co/RNIGSJu1cy „Ç§„É≥„Éâ„Åß„Çπ„Éë„Ç§„ÇØÈÉ®ÂàÜ„ÅÆDNAÈÖçÂàó„Åå1„Ç´ÊâÄÁ™ÅÁÑ∂Â§âÁï∞„Åó„ÄÅ„Çπ„Éë„Ç§„ÇØÈÉ®ÂàÜ„ÅÆÊßãÈÄ†„ÇíÂ§â„Åà„ÅüÂèØËÉΩÊÄß„ÅÆÊÉÖÂ†± https://t.co/28YqeoB2ze‚Ä¶
RT @biorxivpreprint: A virus that has gone viral: Amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact r‚Ä¶
"ùóßùó∂ùòÅùóπùó≤: A virus that has gone viral: Amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding and thus infectivity. ùóîùòÇùòÅùóµùóºùóøùòÄ: Saha, P.; Banerjee, A. K.; Tripathi, P. P.; Sriv... https://t.co/DGL13iZ2QW https://"
A new mutation of #SARSCoV2 at position 144 at the Receptor Bindibg Domain of an #Indian isolate differs from viral sequences from #wuhan and #Italy and could affect infectivity and the development of therapeutics https://t.co/yu8EClQeV6 https://t.co/ViQhq
@influenzer3 „ÅäÁñ≤„ÇåÊßò„Åß„Åô„ÄÇÊú¨Êó•„ÅÆÊÉÖÂ†±„Åß„Åô„ÄÇ https://t.co/RNIGSJu1cy „Ç§„É≥„Éâ„Åß„Çπ„Éë„Ç§„ÇØÈÉ®ÂàÜ„ÅÆDNAÈÖçÂàó„Åå1„Ç´ÊâÄÁ™ÅÁÑ∂Â§âÁï∞„Åó„ÄÅ„Çπ„Éë„Ç§„ÇØÈÉ®ÂàÜ„ÅÆÊßãÈÄ†„ÇíÂ§â„Åà„ÅüÂèØËÉΩÊÄß„ÅÆÊÉÖÂ†± https://t.co/28YqeoB2ze ‰∏≠ÂõΩ ÊÑüÊüìËÄÖ„ÅÆ‰ΩìÂÜÖ„ÅßÁ™ÅÁÑ∂Â§âÁï∞„ÇíËµ∑„Åì„Åó„ÅüÂèØËÉΩÊÄß„ÄÅÂêå‰∏ÄÊÑüÊüìËÄÖ„Åã„ÇâÁ®ÆÈ°û„ÅÆÊñ∞Âûã„Ç≥„É≠„Éä„ÇíÁô∫Ë¶ã„Åó„Åü„Å®
Amino acid mutation in S protein of Indian isolate of #SarsCoV2 Coronavirus #COVID19 might impact receptor binding and thus infectivity. https://t.co/1cccGSuxVZ https://t.co/NyxLImvZKq
New #SARSCoV preprint: A virus that has gone viral: Amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding and thus infectivity https://t.co/yzqQATzQRz
"Contribute a rapid review or request one for ""A virus that has gone viral: Amino acid mutation in S protein of Indian isolate of Coron..."" (https://t.co/yzqQATzQRz). ""Add"" or ""Request"" w/DOI (10.1101/2020.04.07.029132) at https://t.co/RnurTL3DyM @outbreaks"
New #COVID19 preprint: A virus that has gone viral: Amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding and thus infectivity https://t.co/yzqQATzQRz
RT @nekoneko6663: „Åì„Çå„ÉØ„ÇØ„ÉÅ„É≥„Åß„Åç„Å¶„ÇÇÂäπ„Åã„Å™„Åè„Å™„Çã„Çì„Åò„ÇÉ https://t.co/Wf8fdL7dR7
„Ç≥„É≠„Éä„Åå„ÉØ„ÇØ„ÉÅ„É≥„ÅÆÂÖàÂõû„Çä„Åó„Å¶„Åü„Çä„Åó„Å¶„ÄÇ
RT @nekoneko6663: „Åì„Çå„ÉØ„ÇØ„ÉÅ„É≥„Åß„Åç„Å¶„ÇÇÂäπ„Åã„Å™„Åè„Å™„Çã„Çì„Åò„ÇÉ
A virus that has gone viral: Amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding and thus infectivity https://t.co/6bMXWldACP
„Åì„Çå„ÉØ„ÇØ„ÉÅ„É≥„Åß„Åç„Å¶„ÇÇÂäπ„Åã„Å™„Åè„Å™„Çã„Çì„Åò„ÇÉ
"This post is a follow up of the original research paper published by 9 Indian Drs. on #COVID„Éº19 (removed 2 mos. ago) suggesting (not ‚Äòconcluding‚Äô 4 unknown reasons) 4 HIV amino acids were inserted into the virus,thus adding a pathogen that destroys T-1 cel"
Indian isolate of SARS-CoV-2 shows mutation in S protein and could impact receptor binding and thus infectivity #COVID__19 #SARSCoV2 https://t.co/5GCBsGRoTu
RT @PremTripathi83: Excited to share our co-corresponding preprint on coronavirus describing Spike protein mutation in Indian isolates impa‚Ä¶
Changes in the RBD in the first season of infection... ...not good news üôÑ
„ÇìÔΩû „Äå„Ç§„É≥„Éâ„Åß COVID-19 „ÅÆÊÑüÊüìÂäõ„Å´ÂΩ±Èüø„Çí‰∏é„Åà„ÇãÈÅ∫‰ºùÂ≠êÂ§âÁï∞„ÇíÁô∫Ë¶ã„Äç„Å£„Å¶‰∫ã„Åß„ÅÑ„ÅÑ„ÅÆ„Åã„Å™„ÄÇü§î
#SARSCoV2 preprint: Population genomics insights into the recent evolution of SARS-CoV-2 https://t.co/imwi5j9uND
RT @outbreaksci: New #SARSCoV preprint: Population genomics insights into the recent evolution of SARS-CoV-2 https://t.co/eTkdjHAAVn
New #SARSCoV preprint: Population genomics insights into the recent evolution of SARS-CoV-2 https://t.co/eTkdjHAAVn
"Contribute a rapid review or request one for ""Population genomics insights into the recent evolution of SARS-CoV-2"" (https://t.co/eTkdjHAAVn). ""Add"" or ""Request"" w/DOI (10.1101/2020.04.21.054122) at https://t.co/RnurTL3DyM @outbreaksci @PREreview_"
New #COVID19 preprint: Population genomics insights into the recent evolution of SARS-CoV-2 https://t.co/eTkdjHAAVn
RT @MuinJKhoury: Using population genetics analysis to infer the mutation rate and plausible recombination events that contribute to the ev‚Ä¶
"RT @nidaios: our popgen analysis on SARS-CoV-2 https://t.co/ZZtkeDPWVG selective sweeps, ABC demography, mutation, recombination, sumstats‚Ä¶"
Population genomics insights into the recent evolution of SARS-CoV-2 https://t.co/Q9BPHmB5oR
Using population genetics analysis to infer the mutation rate and plausible recombination events that contribute to the evolution of the SARS-CoV-2 virus. #COVID19 Via @biorxivpreprint https://t.co/TfTic0IQnP https://t.co/esrgFjuHF5
RT @biorxiv_evobio: Population genomics insights into the recent evolution of SARS-CoV-2 https://t.co/Zc5obZgKAm #biorxiv_evobio
"Our popgen analysis on SARS-CoV-2 https://t.co/F6XZWfcOap selective sweeps, ABC demography, mutation, recombination, sumstats @biorxivpreprint @biorxiv_evobio @SARS-CoV-2 https://t.co/F6XZWfcOap"
"our popgen analysis on SARS-CoV-2 https://t.co/ZZtkeDPWVG selective sweeps, ABC demography, mutation, recombination, sumstats @biorxivpreprint @biorxiv_evobio"
RT @AlbertVilella: bioRxiv #preprint doi: https://t.co/ROTGfVRj1c. @albertvilella https://t.co/p67cGuRptV
bioRxiv #preprint doi: https://t.co/ROTGfVRj1c. @albertvilella https://t.co/ehjGD1pscZ
bioRxiv #preprint doi: https://t.co/ROTGfVRj1c. @albertvilella https://t.co/d4c1OuG3kx
bioRxiv #preprint doi: https://t.co/ROTGfVRj1c. @albertvilella https://t.co/p67cGuRptV
bioRxiv #preprint doi: https://t.co/ROTGfVRj1c. #SARS_CoV #sequence #population #parameter #preprint_preprint #bioRxiv_preprint #CoV_genome #genome #analysis #recombination #SARS_CoV_2 #Population_genetics #Recombination
Population genomics insights into the recent evolution of SARS-CoV-2 https://t.co/Zc5obZgKAm #biorxiv_evobio
Population genomics insights into the recent evolution of SARS-CoV-2 https://t.co/h4GAgBA6d9 #bioRxiv
"Contribute a rapid review or request one for ""Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine e..."" (https://t.co/TbFCPWtpMu). ""Add"" or ""Request"" w/DOI (10.1101/2020.03.26.009209) at https://t.co/RnurTL3DyM @outbreaks"
New #SARSCoV preprint: Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopes https://t.co/TbFCPWtpMu
New #COVID19 preprint: Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopes https://t.co/TbFCPWtpMu
https://t.co/3YA7s7F7PJ
RT @biorxiv_immuno: Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and‚Ä¶
RT @biorxivpreprint: Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell an‚Ä¶
üìù Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopes medRxiv or bioRxiv https://t.co/2UmKOyqBPP #COVID19 #COVID19Papers #SARSCoV2
Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopes https://t.co/7wG4qTWOiE #biorxiv_immuno
Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopes https://t.co/AhaKFnr6Oq #bioRxiv
"Contribute a rapid review or request one for ""Genomic, geographic and temporal distributions of SARS-CoV-2 mutations"" (https://t.co/EGwbUr8I3m). ""Add"" or ""Request"" w/DOI (10.1101/2020.04.22.055863) at https://t.co/RnurTL3DyM @outbreaksci @PREreview_"
"Updated #SARSCoV preprint: Genomic, geographic and temporal distributions of SARS-CoV-2 mutations https://t.co/EGwbUr8I3m"
"RT @SarabiElly: Genomic, geographic and temporal distributions of SARS-CoV-2 mutations https://t.co/gBE0fLiON7"
"Genomic, geographic and temporal distributions of SARS-CoV-2 mutations Hsin-Chou Yang, Chun-houh Chen, Jen-Hung Wang, Hsiao-Ch Liao, Chih-Ting Yang, Chia-Wei Chen, Yin-Chun Lin, Chiun-How Kao, James C. Liao bioRxiv 2020.04.22.055863; doi: https://t.co/u8ur"
"New #SARSCoV preprint: Genomic, geographic and temporal distributions of SARS-CoV-2 mutations https://t.co/EGwbUr8I3m"
"RT @biorxivpreprint: Genomic, geographic and temporal distributions of SARS-CoV-2 mutations https://t.co/6LsF0Ii3Ic #bioRxiv"
"Genomic, geographic and temporal distributions of SARS-CoV-2 mutations https://t.co/gBE0fLiON7"
"Genomic, geographic and temporal distributions of SARS-CoV-2 mutations https://t.co/J7jGhFvcE2 #biorxiv_micrbio"
"Genomic, geographic and temporal distributions of SARS-CoV-2 mutations https://t.co/6LsF0Ii3Ic #bioRxiv"
Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications [NEW RESULTS] https://t.co/YGtHCsyyCs
"Contribute a rapid review or request one for ""Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and the..."" (https://t.co/ZC8pv3DBWh). ""Add"" or ""Request"" w/DOI (10.1101/2020.05.05.079939) at https://t.co/RnurTL3DyM @outbreaks"
New #SARSCoV preprint: Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications https://t.co/ZC8pv3DBWh
RT @biorxivpreprint: Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications https://t.co/‚Ä¶
üëá
Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications https://t.co/gaqgVtrwvA #biorxiv_bioinfo
Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications https://t.co/rjLKKQfN9M #bioRxiv
"Contribute a rapid review or request one for ""Insights into The Codon Usage Bias of 13 Severe Acute Respiratory Syndrome Coronavirus 2..."" (https://t.co/sbzltPT84m). ""Add"" or ""Request"" w/DOI (10.1101/2020.04.01.019463) at https://t.co/RnurTL3DyM @outbreaks"
Updated #SARSCoV preprint: Insights into The Codon Usage Bias of 13 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Isolates from Different Geo-locations https://t.co/sbzltPT84m
Updated #COVID19 preprint: Insights into The Codon Usage Bias of 13 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Isolates from Different Geo-locations https://t.co/sbzltPT84m
Insights into The Codon Usage Bias of 13 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Isolates from Different Geo-locations https://t.co/CUnhL4b7Rm #glycotime
New #SARSCoV preprint: Insights into The Codon Usage Bias of 13 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Isolates from Different Geo-locations https://t.co/sbzltPT84m
Insights into The Codon Usage Bias of 13 Severe Acute Respiratory Syndrome Coronavirus 2 - https://t.co/C4ZsbEIXD5 #GoogleAlerts
New #COVID19 preprint: Insights into The Codon Usage Bias of 13 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Isolates from Different Geo-locations https://t.co/sbzltPT84m
RT @biorxivpreprint: Insights into The Codon Usage Bias of 13 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Isolates from Di‚Ä¶
Insights into The Codon Usage Bias of 13 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Isolates from Different Geo-locations https://t.co/1SsNLiKXMD
üìù Insights into The Codon Usage Bias of 13 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Isolates from Different Geo-locations medRxiv or bioRxiv https://t.co/S62USOXiVW #COVID19 #COVID19Papers #SARSCoV2
RT @biorxiv_genomic: Insights into The Codon Usage Bias of 13 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Isolates from Di‚Ä¶
Insights into The Codon Usage Bias of 13 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Isolates from Different ... https://t.co/862248IC7H #biorxiv_genomic
Insights into The Codon Usage Bias of 13 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Isolates from Different Geo-locations https://t.co/JJ3t2EGvcv #bioRxiv
"Contribute a rapid review or request one for ""Quality control of low-frequency variants in SARS-CoV-2 genomes"" (https://t.co/IoSCiYaXFP). ""Add"" or ""Request"" w/DOI (10.1101/2020.04.26.062422) at https://t.co/RnurTL3DyM @outbreaksci @PREreview_"
Updated #SARSCoV preprint: Quality control of low-frequency variants in SARS-CoV-2 genomes https://t.co/IoSCiYaXFP
"The ABC of a genome coverage, COVID-19 and beyond: ""...genomes with multiple singletons even marked as high-covered should be considered with caution"" https://t.co/33C2Ibslhu"
RT @biorxiv_genomic: Quality control of low-frequency variants in SARS-CoV-2 genomes https://t.co/UZdknQXsBQ #biorxiv_genomic
RT @OmicsOmicsBlog: Interesting look at how SARS-CoV-2 genome variant uniqueness tracks with sequencing technology and assembly method http‚Ä¶
New #SARSCoV preprint: Quality control of low-frequency variants in SARS-CoV-2 genomes https://t.co/IoSCiYaXFP
Interesting look at how SARS-CoV-2 genome variant uniqueness tracks with sequencing technology and assembly method https://t.co/n55R06b3iQ
RT @bxv_genomics: Quality control of low-frequency variants in SARS-CoV-2 genomes https://t.co/EyDR3i0coG
Quality control of low-frequency variants in SARS-CoV-2 genomes https://t.co/EyDR3i0coG
RT @biorxivpreprint: Quality control of low-frequency variants in SARS-CoV-2 genomes https://t.co/ZedVSdCDmq #bioRxiv
Quality control of low-frequency variants in SARS-CoV-2 genomes https://t.co/UZdknQXsBQ #biorxiv_genomic
Quality control of low-frequency variants in SARS-CoV-2 genomes https://t.co/ZedVSdCDmq #bioRxiv
